IDEXX Laboratories, Inc. (IDXX) fair value analysis

S&P 500 & Nasdaq · Updated 2026-09-07

IDEXX Laboratories, Inc. manufactures and distributes diagnostic equipment, software, and consumables for veterinary, water, and dairy testing purposes. The company operates globally with a presence in multiple countries across North America, Europe, Asia, and other international markets.

Forward Fair Value verdict

Undervalued

Based on TickrTrends' weekly Forward Fair Value model, IDXX is trading at more than a 25% discount to estimated fair value.

IDXX currently ranks #28 of 113 Healthcare stocks by discount to Forward Fair Value. It has screened as Undervalued for 3 consecutive weekly runs.

Last price: $535.38
Sector: Healthcare
12-month range: $545.16–$728.97

Derived indicators

Coarse bands from TickrTrends' weekly models; exact figures are part of the full report.

Quality grade: B
Leverage: Moderate
Margin trend: Expanding
Revenue growth: Strong
RSI zone: Neutral
50/200-day trend: Downtrend
52-week position: The bottom quarter of its range

What our data shows for IDXX

Our model validated 17 trailing price-to-earnings windows for IDXX, built from quarterly earnings records.
Shares are trading in the lower third of their 12-month price range of $545.16–$728.97.
The 14-day relative strength index sits at a neutral 36.

The exact numbers are one step away

The precise Forward Fair Value dollar figure for IDXX
Exact discount / premium to today's price
The normalized historical P/E behind the estimate, and how many quarters support it
Forward EPS input and fiscal-year basis
Screeners and rankings across the full S&P 500 and Nasdaq universes

See the exact fair value →

How Forward Fair Value works

TickrTrends computes a Forward Fair Value for every covered stock each week: a conservatively normalized historical price-to-earnings multiple is applied to the analyst-consensus earnings estimate for the next full fiscal year. Every input window is validated for continuity and every result is screened for plausibility before publication.

Recent IDXX news

TickrTrends' derived news-sentiment signal for IDXX is currently leaning positive, computed from recent coverage.

Are Wall Street Analysts Predicting IDEXX Laboratories Stock Will Climb or Sink? (finance.yahoo.com, 2026-08-26)
TickrTrends take: IDEXX Laboratories operates in the Healthcare sector where TickrTrends currently derives an undervalued verdict for the stock. Wall Street analyst predictions about the company's direction represent one input among many that valuation-focused investors monitor alongside earnings fundamentals, competitive positioning, and sector trends. For readers focused on valuation assessment, tracking both analyst sentiment and the company's ability to execute on its business operations will be relevant to understanding whether the undervalued designation may shift over time.
Rationale Behind Baron Focused Growth Fund’s IDEXX Laboratories (IDXX) Holding (finance.yahoo.com, 2026-08-20)
TickrTrends take: The Baron Focused Growth Fund's continued holding in IDEXX Laboratories reflects confidence in the company's long-term prospects within the healthcare sector. Given TickrTrends' current assessment that IDXX is undervalued, investors monitoring valuation metrics should track whether the company's financial performance supports closing the gap between its current price and intrinsic value estimates. The fund's positioning may indicate that institutional investors see meaningful upside potential in the stock relative to its present valuation standing.

What people are saying

Follow the IDXX conversation: Stocktwits · Reddit · X

TickrTrends weekly updates

2026-09-07 — No material change this week: the verdict, bands and grades all held steady.
2026-09-06 — No material change this week: the verdict, bands and grades all held steady.
2026-08-31 — TickrTrends initiated weekly Forward Fair Value coverage of this stock.

Frequently asked questions

Is IDXX stock undervalued?

Based on TickrTrends' Forward Fair Value model (updated 2026-09-07), IDXX is trading at more than a 25% discount to estimated fair value and screens as undervalued. The exact fair value and discount are available to subscribers.

What is IDXX's TickrTrends verdict?

IDXX's current verdict is Undervalued, refreshed with every weekly Forward Fair Value run.

How does IDXX compare to other Healthcare stocks?

IDXX ranks #28 of 113 Healthcare stocks in TickrTrends' coverage when sorted by discount to Forward Fair Value.

Is IDXX overbought or oversold?

IDXX's 14-day RSI is in neutral territory - neither overbought nor oversold.

All Healthcare fair-value coverage →

Head-to-head comparisons

IDXX vs AVAH · IDXX vs GEHC · IDXX vs HSTM · IDXX vs INDV · IDXX vs OFIX